CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 57 filers reported holding CTI BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,400,000 | -24.5% | 2,000,000 | +8.1% | 2.48% | -47.7% |
| Q4 2022 | $11,119,000 | -4.5% | 1,850,000 | -7.5% | 4.75% | +45.3% |
| Q3 2022 | $11,640,000 | +143.7% | 2,000,000 | +150.0% | 3.27% | +31.3% |
| Q2 2022 | $4,776,000 | -21.3% | 800,000 | -38.5% | 2.49% | +88.9% |
| Q1 2022 | $6,071,000 | +104.0% | 1,300,000 | +8.3% | 1.32% | +23.4% |
| Q4 2021 | $2,976,000 | -36.9% | 1,200,000 | -25.0% | 1.07% | -22.7% |
| Q3 2021 | $4,720,000 | +18.0% | 1,600,000 | 0.0% | 1.38% | +25.5% |
| Q2 2021 | $4,000,000 | +83.2% | 1,600,000 | +113.3% | 1.10% | +114.4% |
| Q1 2021 | $2,183,000 | -9.6% | 750,000 | 0.0% | 0.51% | -4.6% |
| Q4 2020 | $2,415,000 | – | 750,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |